Comparison of HDAC Inhibitors in Clinical Development

Human Vaccines and Immunotherapeutics - United States
doi 10.4161/hv.23800
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

HDAC Inhibitors Show Benefits in Breast Cancer

Cancer Discovery
Oncology
2011English

Identification of HDAC Inhibitors Using a Cell-Based HDAC I/Ii Assay

Journal of Biomolecular Screening
Molecular MedicinePharmacologyBiochemistryAnalytical ChemistryBiotechnologyDrug Discovery
2016English

Development of an ELISA-Based HDAC Activity Assay for Characterization of Isoform-Selective Inhibitors

Journal of Biomolecular Screening
Molecular MedicinePharmacologyBiochemistryAnalytical ChemistryBiotechnologyDrug Discovery
2015English

HDAC Inhibitors in Experimental Liver and Kidney Fibrosis

Fibrogenesis and Tissue Repair
DermatologyMedicineHepatologyRheumatologyGastroenterology
2013English

Effects of Novel HDAC Inhibitors on Urothelial Carcinoma Cells

Clinical Epigenetics
GeneticsDevelopmental BiologyMolecular Biology
2018English

New and Emerging HDAC Inhibitors for Cancer Treatment

Journal of Clinical Investigation
Medicine
2014English

HDAC Inhibitors Stimulate Viral Transcription by Multiple Mechanisms

Virology Journal
VirologyInfectious Diseases
2008English

HDAC Inhibitors Enhance the Immunotherapy Response of Melanoma Cells

Oncotarget
Oncology
2017English

HDAC Inhibitors as Antifibrotic Drugs in Cardiac and Pulmonary Fibrosis

Therapeutic Advances in Chronic Disease
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy